Researchers Identified Protein Vulnerability in Cancer Cells
A new study reveals that blocking specific proteins can destabilize extrachromosomal DNA in human cancer cells.
Updated on Oct. 2, 2026 in Cancer
Live Poll
Does learning about new cancer treatment research increase your trust in future medical breakthroughs?
Researchers have discovered that targeting specific DNA repair proteins can cause the collapse of extrachromosomal DNA in cancer cells. The findings suggest a new therapeutic pathway for treating aggressive, treatment-resistant tumors.
Why it matters
Cancer cells rely on internal repair mechanisms to maintain fragile extrachromosomal DNA structures that drive rapid growth and resistance to treatment. Disrupting these processes may offer a way to selectively eliminate the DNA that fuels cancer progression.
Approximately 1 in 6 human cancers rely on extrachromosomal DNA, which exhibits structural fragility due to repetitive TA sequences. The research analyzed patterns in prostate, gastric, and colorectal cancer cell lines.
The players
Memorial Sloan Kettering Cancer Center
This is a world-renowned cancer treatment and research institution that served as the primary site for the study.
Nature
Nature is a prominent international multidisciplinary scientific journal that publishes peer-reviewed research.
The details
The study found that repetitive TA sequences in ecDNA create cross-shaped structures that are prone to breakage, which the protein FANCM normally helps prevent. By using experimental inhibitors to block the repair protein polymerase theta, researchers caused irreparable damage and the subsequent loss of ecDNA in tested cancer cell lines.
Timeline
September 23, 2026: The research team published their findings in the journal Nature.
The Big Picture
This discovery extends the current understanding of genomic instability established by the National Cancer Institute's extrachromosomal DNA research initiatives. The findings shift the focus of cancer therapy toward targeting the specific repair mechanisms that preserve fragile genetic structures.
This breakthrough identifies a potential therapeutic target that could lead to new drugs designed to weaken aggressive tumors. While these findings are currently confined to laboratory research, they represent a long-term goal for developing combination treatments that counter drug resistance.
The takeaway
Targeting the repair mechanisms of cancer cells represents a promising strategy for overcoming treatment resistance. Future clinical developments may focus on combination therapies that simultaneously prevent and repair genetic breaks to eliminate cancer growth.
Further reading
For more on evolving treatment strategies, visit the Cancer section.
More information
Read the full study publication in Nature to learn more about the methodology.
Live Poll
Does learning about new cancer treatment research increase your trust in future medical breakthroughs?
